DrugPatentWatch Database Preview
Teva Parenteral Company Profile
» See Plans and Pricing
What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?
TEVA PARENTERAL has forty-seven approved drugs.
There are six tentative approvals on TEVA PARENTERAL drugs.
Summary for Teva Parenteral
| US Patents: | 0 |
| Tradenames: | 39 |
| Ingredients: | 37 |
| NDAs: | 47 |
Drugs and US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Parenteral | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 074784-001 | Jun 11, 1997 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | IDARUBICIN HYDROCHLORIDE | idarubicin hydrochloride | INJECTABLE;INJECTION | 065037-003 | May 1, 2002 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 200875-001 | Sep 11, 2014 | AN | RX | No | No | Start Trial | Start Trial | ||||
| Teva Parenteral | IDARUBICIN HYDROCHLORIDE | idarubicin hydrochloride | INJECTABLE;INJECTION | 065037-001 | May 1, 2002 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 081267-001 | Nov 30, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 081125-001 | Aug 31, 1990 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-001 | Approved Prior to Jan 1, 1982 | 3,444,294 | Start Trial |
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-002 | Approved Prior to Jan 1, 1982 | 3,444,294 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
